NEW ORLEANS, LA—Adding the factor XIa inhibitor asundexian (Bayer) to antiplatelet therapy tops antiplatelet therapy alone ...

Stroke patients treated intravenously with loberamisal, a novel neuroprotective medication, daily for 10 days and starting within 48 hours of stroke symptoms, had better recovery than patients who ...

Recent research has revealed compelling evidence supporting tenecteplase as a more effective treatment for ischemic strokes compared to traditional alteplase therapy. This discovery could mark a major ...

Stroke during pregnancy or shortly after delivery is rare, yet it can be life-threatening. Increased awareness and ...

When Cheryl Hamrick woke up in the middle of the night, she didn’t know what time it was. It was the awful pain radiating from the right side of the back of her head that was at the forefront of her ...

The American Heart Association and American Stroke Association have issued an updated guideline for the diagnosis and treatment of acute ischemic stroke.The new guideline, published in Stroke, ...

David Altschul, MD, Director of Neurovascular Surgery, Co-Director of Montefiore Comprehensive Stroke Center; Allan Brook, MD, Neuroradiology; Daniel Labovitz, MD, Neurology, Vascular Neurology, for ...

New stroke breakthroughs spotlight faster treatment, factor XI prevention, better recovery, and the push to deliver care equitably with smart wearables. The future of stroke care is likely to be ...

The American Heart Association released a scientific statement on preventing and treating maternal stroke during pregnancy and postpartum.

Innovations in stroke diagnostics and treatment techniques are saving brains — and lives — and making it possible to reverse disability from stroke. Since most strokes are “ischemic,” or caused by a ...

In Alaska, where access to specialist care is challenging and emergency transfers can be harrowing, providers are using AI to speed up diagnosis and improve treatment Healthcare access and treatment ...

George Harston, MD, chief medical and innovation officer for Oxford, U.K.-based Brainomix, said the appeal of the company’s technology is fairly simple. In explaining the company’s variety of ...